Moderna created its shots with the U.S. National Institutes of Health and already had a hint they were working, but said it got the final needed results over the weekend that suggest the vaccine is more than 94% effective.
Moderna is just behind Pfizer and its German partner BioNTech in seeking to begin vaccinations in the U.S. in December. Across the Atlantic, British regulators also are assessing the Pfizer shot and another from AstraZeneca.

Swiss Re to set up new fund for institutional and designated investors to access Nat Cat biz

Nov 30, 2020

Martin Bisping, CEO of Swiss Re Insurance-Linked Investment Management said: “This new fund will open a unique opportunity for investors to invest in the same book of business as Swiss Re, benefitting from Swiss Re’s global reach, client access, risk knowledge and underwriting.“

Russian hospital says it began civilian coronavirus vaccinations last week

Nov 30, 2020

Domodedovo’s Central City Hospital said on its website that residents wanting for inoculation had to register on a government website in advance and bring along a negative COVID-19 test result and ID documents on the day.

Pandemic Motors: Europeans snap up old cars to avoid public transport

Nov 30, 2020

The surge in interest in used cars is neither good news for struggling mass transit networks nor the environment as dirty old cars appear to be more in demand than new electric vehicles.

In the longer term, however, the shift away from public transport towards “individual mobility” in the pandemic era is expected to help carmakers, hit by a 27% slump in new vehicle sales across Europe in the first 10 months of 2020.

« Older Entries

Next Entries »

Briefs